Foundayo Ships Week 2: How to Order Eli Lilly's GLP-1 Pill Right Now (April 2026)
Launch record updated August 14, 2026: Foundayo began shipping April 6. Its $649 figure is WAC/list price, not the current LillyDirect self-pay total. Cash pricing now runs $149-$349 by dose and refill timing; eligible commercial-insurance savings may lower the copay.
Summarize this article with
Foundayo (orforglipron) began shipping through LillyDirect on April 6, 2026, five days after its April 1 FDA approval. The $649 launch figure is WAC/list price, not today's LillyDirect self-pay total. As checked August 14, cash pricing is $149/month at 0.8 mg; $199 at 2.5 mg; $299 at 5.5 mg or 9 mg; and $299 at 14.5 mg or 17.2 mg only when refilled within 45 days, otherwise $349. Eligible commercially insured patients may pay as little as $25 under the savings-card terms. Foundayo is a non-peptide GLP-1 pill with no fasting or injection requirement.
Quick answer: how to get Foundayo this week.
- •LillyDirect: Go to lilly.com/lillydirect/medicines/foundayo. A prescription is required. Confirm the dose-specific $149-$349 cash price and, for 14.5 mg or 17.2 mg, whether the 45-day refill condition is met.
- •Commercial insurance + Lilly savings card ($25/mo): Get a prescription from your doctor. Activate the savings card at foundayo.lilly.com/savings. Fill at a retail pharmacy (CVS, Walgreens, Walmart), rollout completes by April 15.
- •Telehealth providers: LillyDirect is the only authorized channel this week. Telehealth availability begins April 14, expect Sprout Health, Enhance MD, and other established platforms to offer it first based on their Lilly relationships.
- •Medicare patients: Foundayo IS covered by the Medicare GLP-1 Bridge at $50/month for eligible Part D beneficiaries live as of July 1, 2026. Foundayo is one of four drugs included in the Bridge (alongside Wegovy injection, Wegovy oral, and Zepbound KwikPen). See our Bridge enrollment guide for eligibility requirements and the BMI-based routing rule.
- •Cash-pay backup if Foundayo is out of stock: NovoCare Wegovy pill from $149/mo or pen at $199/mo for the first two low-dose fills, then $349/mo at standard strengths ($399 HD), or LillyDirect Zepbound from $299/mo at the starter dose. Compounded alternatives advertise lower entry prices, including Enhance MD tirzepatide from $99 first month or semaglutide from $49 first month; confirm the patient-specific prescription and pharmacy pathway separately.
This is a rapid-response piece on the Foundayo launch. For the full clinical profile (12.4% body weight loss per ATTAIN-1, dosing schedule, side effects, comparison to Wegovy pill), see our complete Foundayo guide and the head-to-head Foundayo vs Wegovy Pill comparison.
Comparing your options?
See every verified GLP-1 program ranked side by side on cost, safety, and care quality. The cheapest we track right now is $69/mo.
Compare all 54 GLP-1 providers →Why Foundayo Matters, The 48-Hour Story
Foundayo's approval and launch compressed a typical 12-18 month FDA-to-shelf cycle into 49 days total (filing to shipping). Eli Lilly used the FDA's National Priority Voucher program, which allows accelerated review for drugs meeting public health priorities. Obesity qualifies because 30M+ Americans are currently on GLP-1 therapy and demand far exceeds injectable capacity.
Three things made this launch unusually fast:
- •Manufacturing was ready. Lilly started scaling orforglipron production in Q3 2025 based on ACHIEVE-1 Phase 3 data, betting on approval. That bet paid off, LillyDirect had starter inventory before the FDA decision.
- •Non-peptide chemistry is easier to scale. Peptide drugs (semaglutide, tirzepatide) require complex bioreactor production. Orforglipron is a small molecule, synthesized via standard pharmaceutical chemistry at higher volumes per batch.
- •Direct-to-consumer channel was pre-built. LillyDirect launched for Zepbound in 2024, so the infrastructure (medical intake, prescriber network, pharmacy fulfillment) was already in place. Foundayo just plugged in.
Join the list for the GLP-1 Letter.
We re-verify every price on this site against the provider's own live page and check every program against the FDA warning letter database. Join the list and you will hear from us when that work turns up something worth an email. No promised schedule until we are actually keeping one. Unsubscribe anytime.
No affiliate spam. No retargeting pixels. Unsubscribe in one click.
What Early Patients Are Reporting (Week 1)
We monitored Reddit (r/Semaglutide, r/Ozempic, r/loseit, r/Foundayo) and X for April 6-11 posts from verified Foundayo patients. The sample is small and unscientific, but the themes are consistent:
- •Nausea is manageable. Most week-1 posts describe mild nausea lasting 24-48 hours after the first dose, then fading. This matches the ATTAIN-1 trial where 16.5% of patients reported nausea vs 4.1% for placebo.
- •The no-fasting pitch is real. Multiple posts emphasized taking Foundayo with coffee and breakfast, something impossible with oral Wegovy's 30-minute fasting window.
- •Appetite suppression kicks in by day 3-4. Similar timeline to injectable GLP-1s.
- •Shipping speed: Most LillyDirect orders arrived within 3-5 business days. A few delays to rural addresses pushed to 7 days.
Not sure which GLP-1 program is right for you?
Take the 60-second quiz, we'll match you against 54 verified providers on your goals, budget, and medication preference, then surface your top 3.
Take the 60-sec QuizPricing Reality Check: $649 WAC vs $149-$349 Self-Pay
Foundayo's $649/month figure is WAC/list price. LillyDirect self-pay is lower and depends on dose and refill timing:
| Medication | Form | Self-Pay Price | Trial Weight Loss |
|---|---|---|---|
| Foundayo (orforglipron) | Daily pill, no fasting | $149-$349/mo (LillyDirect; dose/refill terms) | 12.4% (ATTAIN-1) |
| Oral Wegovy (semaglutide 25mg) | Daily pill, 30-min fast | From $149/mo cash, dose-dependent; $1,349/mo list | 16.6% (OASIS-1) |
| Injectable Wegovy | Weekly injection | $199/mo first two low-dose fills; then $349 standard / $399 HD (NovoCare) | 14.9% (STEP-1) |
| Injectable Zepbound | Weekly injection | $299/mo (LillyDirect 2.5mg) | 20.9% (SURMOUNT-1) |
| Compounded semaglutide | Weekly injection | $146/mo, 6-mo plan (Yucca Health) | Not established for this compounded product; branded-trial outcomes do not transfer |
| Compounded tirzepatide | Weekly injection | $99 first mo, then $280/mo (Enhance MD) | Not established for this compounded product; branded-trial outcomes do not transfer |
A cost-per-percentage-point comparison is defensible only for products with product-specific trial outcomes. Foundayo, oral Wegovy, injectable Wegovy, and Zepbound each have branded trial data listed above. The compounded rows do not, so assigning them the outcomes of branded products would create a false efficacy comparison. Compare their advertised prices separately from the approved brands' trial results.
For a full cost breakdown across every GLP-1 option, see our GLP-1 cost guide or use the cost calculator.
Editor's Top Pick
Embody
from $69/mo · 7.3/10 · Compounded
Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.
What to Watch Next
- •April 14, 2026: Telehealth rollout begins. Expect price competition as Sprout Health, Enhance MD, and other established platforms announce Foundayo programs.
- •April 15, 2026: Retail pharmacy distribution completes (CVS, Walgreens, Walmart). Insurance-covered patients should be able to fill at their usual pharmacy by April 16.
- •May 2026: Lilly earnings call will include first-month Foundayo revenue. Analysts are watching for signs that the pill is eating into Wegovy/Ozempic prescription share.
- •July 1, 2026 (UPDATE): Medicare GLP-1 Bridge is live and DOES cover Foundayo at $50/month for eligible Part D beneficiaries, CMS confirmed Foundayo as one of four Bridge-eligible drugs. Bridge enrollment guide →
- •June 1, 2026 (UPDATE): CVS Caremark added Foundayo to its standard commercial formulary ahead of the typical 3-6 month post-approval window, covering ~25-30 million Americans. CVS simultaneously announced Zepbound formulary restoration effective October 1. Express Scripts and OptumRx decisions pending as of June 2026.
Sources
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1), Wharton S, Aronne LJ, Stefanski A, et al. N Engl J Med 2025;393(18):1796-1806 (DOI: 10.1056/NEJMoa2511774)
- FDA Approves First New Molecular Entity Under National Priority Voucher Program, Foundayo, U.S. Food and Drug Administration, April 1, 2026
- LillyDirect Foundayo Product Page, Eli Lilly
- FDA National Priority Voucher Program, U.S. Food and Drug Administration
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.
Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.
Find your GLP-1 program, our Top Pick is Embody
Our featured pick, drawn from our independent ranking of 54 providers, is listed at from $69/mo.
Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment
Compare every GLP-1 program in one place
See all 54 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.
Medicare & GLP-1
Medicare GLP-1 Coverage Guide
Saw Medicare mentioned in "Foundayo Ships Week 2: How to Order Eli Lilly's GLP-1 Pill Right Now (April 2026)"? Here's exactly what's covered, who qualifies, and how the $50/mo Bridge copay works from July 1, 2026.
Read the Medicare Coverage Guide →Berberine vs Ozempic: Why Berberine Is Not "Nature's Ozempic"
Cost & InsuranceTirzepatide Cost 2026: $149 to $1,086/Month, Every Option Ranked (Verified July 2026)
News & PipelineMedicare GLP-1 Coverage: Everything Changing in July 2026
What the doctors say
Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.
“So-called 'weight loss drugs' like semaglutide have proven benefits beyond reducing the number on the scales. They are now considered important medicines for preventing deadly heart attacks and strokes. Today's guidance will no doubt help save lives as cardiovascular disease is still one of the country's biggest killers.”
“More options for people with these challenging diseases will be very helpful, particularly if the new oral tablet medicines are priced reasonably.”
“People with overweight or obesity have individual preferences, and with oral semaglutide as a potential new treatment option, more of those who are not on treatment today may consider starting GLP-1 treatment.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.